Last updated on December 2018

Evaluation of SPN-812 ER High Dose in Children With ADHD


Brief description of study

This study will evaluate the efficacy and safety of high doses of SPN 812 ER in children with ADHD

Detailed Study Description

This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group study, to assess the efficacy and safety of SPN-812 ER as monotherapy for the treatment of children 6-11 years old with ADHD.

Clinical Study Identifier: NCT03247543

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.